Search Prime Grants

UM1TR006155

Cooperative Agreement

Overview

Grant Description
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD - PROJECT SUMMARY THE PENN-CHOP CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) HUB PROPOSES A TRANSFORMATIVE VISION TO CATALYZE A DYNAMIC CLINICAL AND TRANSLATIONAL SCIENCE (CTS) ECOSYSTEM THAT ACCELERATES THE DELIVERY OF INNOVATIVE, LIFE-ALTERING THERAPIES TO INDIVIDUALS ACROSS THE LIFESPAN. ALIGNED WITH THE NCATS MISSION TO BRING MORE TREATMENTS TO ALL PEOPLE MORE QUICKLY, OUR HUB WILL LEVERAGE ITS NATIONALLY-RECOGNIZED STRENGTHS IN TRANSLATIONAL THERAPEUTICS, DATA SCIENCE, COMMUNITY ENGAGEMENT, AND WORKFORCE DEVELOPMENT TO ADVANCE THE SCIENCE AND PRACTICE OF CLINICAL TRANSLATION. WE PROPOSE FOUR INTEGRATED AIMS: (1) INNOVATE NOVEL APPROACHES TO ADVANCING THE DEVELOPMENT AND DISSEMINATION OF TRANSLATIONAL THERAPEUTICS; (2) ACCELERATE THE APPLICATION OF STATE-OF-THE-ART DATA SCIENCE RESOURCES AND DYNAMIC DATA ECOSYSTEMS TO ENABLE A PENN-CHOP ACADEMIC LEARNING HEALTH SYSTEM (ALHS) FRAMEWORK AND CATALYZE GROUNDBREAKING CTS; (3) INTEGRATE OUR HUB WITH OUR COMMUNITIES AND STAKEHOLDERS TO PROMOTE COMMUNITY-PARTNERED AND COLLABORATIVE RESEARCH WITHIN FAMILIES AND ACROSS THE LIFESPAN; (4) EDUCATE, TRAIN, ADVANCE, AND RETAIN A SKILLED MULTIDISCIPLINARY WORKFORCE READY TO MEET THE DEMAND OF AN EVER-EVOLVING CTS AND AND CTR LANDSCAPE. OUR HUB WILL SERVE AS A NATIONAL MODEL FOR INTEGRATED, COMMUNITY-ENGAGED, AND DATA-DRIVEN TRANSLATIONAL SCIENCE. THROUGH RIGOROUS EVALUATION, CONTINUOUS QUALITY IMPROVEMENT, AND DISSEMINATION OF BEST PRACTICES, WE AIM TO CONTRIBUTE MEANINGFULLY TO THE CTSA CONSORTIUM'S COLLECTIVE IMPACT ON PUBLIC HEALTH.
Funding Goals
NOT APPLICABLE
Place of Performance
Philadelphia, Pennsylvania 191045127 United States
Geographic Scope
Single Zip Code
Trustees Of The University Of Pennsylvania was awarded Penn-CHOP CTSA Hub: Advancing Clinical Translation Cooperative Agreement UM1TR006155 worth $10,805,594 from National Center for Advancing Translational Sciences in July 2026 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 6 years 10 months and was awarded through assistance program 93.350 National Center for Advancing Translational Sciences. The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 7/6/26

Period of Performance
7/1/26
Start Date
5/31/33
End Date
0% Complete

Funding Split
$10.8M
Federal Obligation
$0.0
Non-Federal Obligation
$10.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UM1TR006155

Additional Detail

Award ID FAIN
UM1TR006155
SAI Number
UM1TR006155-791283393
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
GM1XX56LEP58
Awardee CAGE
7G665
Performance District
PA-03
Senators
Robert Casey
John Fetterman
Modified: 7/6/26